Stability studies in the pharmaceutical industry are designed to evaluate how the quality of a drug substance or product varies with time under the influence of environmental factors such as temperature, humidity, and light. These studies ensure that pharmaceuticals maintain their safety, efficacy, and quality throughout their shelf life.
ICH guidelines, such as Q1A(R2) for stability testing of new drug substances and products, provide a comprehensive framework for designing and conducting stability studies. These guidelines outline critical aspects of stability testing, including:
At Tentamus Pharma UK, stability studies are meticulously planned and executed in accordance with ICH guidelines using five in-house stability cabinets. These cabinets provide the controlled environments necessary for testing drugs under various specified conditions:
Ensures accurate and consistent temperature settings.
Maintains specified humidity levels for testing.
Controls light conditions to assess the impact of light on product stability.
Detailed documentation of study protocols, sample analysis results, and conclusions is maintained to demonstrate compliance with regulatory requirements. This includes:
1. Study Protocols - Documenting the detailed plans and procedures for each stability study.
2. Sample Analysis Results - Recording the outcomes of all tests conducted during the study.
3. Conclusions - Summarising the findings and implications for product shelf life and quality.
Tentamus Pharma UK ensures that stability studies are conducted to the highest standards, contributing to the quality, safety, and efficacy of pharmaceutical products throughout their lifecycle. Our commitment to following ICH guidelines and maintaining rigorous documentation practices helps us deliver reliable and compliant stability data to our clients.